Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 36,190 | 24,304 | 21,966 | 24,417 | 19,152 |
| Operating Income | -36,190 | -24,304 | -21,966 | -24,417 | -19,152 |
| Other Income | 1,153 | 1,335 | 1,411 | 1,075 | 1,490 |
| Pre-tax Income | -35,037 | -22,969 | -20,555 | -23,342 | -17,662 |
| Net Income Continuous | -35,037 | -22,969 | -20,555 | -23,342 | -17,662 |
| Net Income | $-35,037 | $-22,969 | $-20,555 | $-23,342 | $-17,662 |
| EPS Basic Total Ops | -1.81 | -1.23 | -1.17 | -1.90 | -1.44 |
| EPS Basic Continuous Ops | -1.81 | -1.23 | -1.17 | -1.90 | -1.44 |
| EPS Diluted Total Ops | -1.81 | -1.23 | -1.17 | -1.90 | -1.44 |
| EPS Diluted Continuous Ops | -1.81 | -1.23 | -1.17 | -1.90 | -1.44 |
| EPS Diluted Before Non-Recurring Items | -1.81 | -1.23 | -1.25 | -1.90 | -1.44 |
| EBITDA(a) | $-36,365 | $-24,601 | $-22,609 | $-24,417 | $-19,519 |